Plasmid DNA Manufacturing Market Revenue 2024 to 2034
Plasmid DNA Manufacturing Market Revenue 2024 to 2034
The global plasmid DNA manufacturing market was estimated at US$ 1.85 billion in 2023 and is projected to grow to US$ 12.27 billion by 2034, rising at a compound annual growth rate (CAGR) of 18.77% from 2024 to 2034.
Report ID: 10235
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 2.20 Bn
Forecast Year,
USD USD 12.27 Bn
CAGR, 2025 -
18.77%
Report Coverage
Worldwide
Published By
Yogesh Kulkarni
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Plasmid DNA Manufacturing Market Size Analysis
Plasmid DNA Manufacturing Market Size Product 2024 to 2034 (USD )
| Product | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Viral Vectors | 550.00 | 647.14 | 761.36 | 895.67 | 1053.58 | 1239.20 | 1457.39 | 1713.83 | 2015.19 | 2369.29 | 2785.34 |
| Plasmid DNA | 660.00 | 802.17 | 974.46 | 1183.17 | 1435.90 | 1741.81 | 2111.98 | 2559.74 | 3101.18 | 3755.69 | 4546.65 |
| Non-Viral | 220.00 | 255.20 | 295.86 | 342.79 | 396.91 | 459.28 | 531.08 | 613.65 | 708.51 | 817.35 | 942.10 |
| Electroporation | 264.00 | 313.55 | 372.41 | 442.31 | 525.33 | 623.93 | 741.04 | 880.14 | 1045.34 | 1241.55 | 1474.59 |
| Lipid/Polymer | 176.00 | 209.04 | 248.27 | 294.87 | 350.22 | 415.96 | 494.03 | 586.76 | 696.89 | 827.70 | 983.06 |
| Nanoparticles | 220.00 | 261.29 | 310.34 | 368.59 | 437.77 | 519.94 | 617.54 | 733.45 | 871.12 | 1034.63 | 1228.83 |
| Others | 110.00 | 124.55 | 140.69 | 158.49 | 178.03 | 199.31 | 222.31 | 246.93 | 272.95 | 300.04 | 327.69 |
Plasmid DNA Manufacturing Market Size Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gene Therapy | 880.00 | 1063.47 | 1284.80 | 1551.76 | 1873.67 | 2261.76 | 2729.52 | 3293.19 | 3972.30 | 4790.32 | 5775.48 |
| DNA Vaccines | 550.00 | 644.09 | 754.12 | 882.77 | 1033.15 | 1208.87 | 1414.16 | 1653.93 | 1933.88 | 2260.66 | 2641.98 |
| Immunotherapy | 550.00 | 653.24 | 775.85 | 921.47 | 1094.43 | 1299.86 | 1543.84 | 1833.62 | 2177.79 | 2586.57 | 3072.06 |
| Others | 220.00 | 252.15 | 288.62 | 329.89 | 376.49 | 428.95 | 487.85 | 553.75 | 627.20 | 708.72 | 798.74 |
Plasmid DNA Manufacturing Market Size Disease 2024 to 2034 (USD )
| Disease | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Infectious Disease | 770.00 | 905.38 | 1064.46 | 1251.36 | 1470.92 | 1728.81 | 2031.70 | 2387.38 | 2805.00 | 3295.28 | 3870.80 |
| Cancer | 880.00 | 1063.47 | 1284.80 | 1551.76 | 1873.67 | 2261.76 | 2729.52 | 3293.19 | 3972.30 | 4790.32 | 5775.48 |
| Genetic Disorder | 550.00 | 644.09 | 754.12 | 882.77 | 1033.15 | 1208.87 | 1414.16 | 1653.93 | 1933.88 | 2260.66 | 2641.98 |
Plasmid DNA Manufacturing Market Size Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 770.00 | 905.38 | 1064.46 | 1251.36 | 1470.92 | 1728.81 | 2031.70 | 2387.38 | 2805.00 | 3295.28 | 3870.80 |
| Asia Pacific | 594.00 | 723.78 | 881.36 | 1072.60 | 1304.57 | 1585.83 | 1926.72 | 2339.70 | 2839.84 | 3445.31 | 4178.01 |
| Europe | 484.00 | 565.70 | 661.02 | 772.19 | 901.81 | 1052.89 | 1228.90 | 1433.89 | 1672.55 | 1950.27 | 2273.33 |
| Latin America | 176.00 | 209.04 | 248.27 | 294.87 | 350.22 | 415.96 | 494.03 | 586.76 | 696.89 | 827.70 | 983.06 |
| Middle East and Africa | 176.00 | 209.04 | 248.27 | 294.87 | 350.22 | 415.96 | 494.03 | 586.76 | 696.89 | 827.70 | 983.06 |
Plasmid DNA Manufacturing Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
